Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sobel, E.
Right arrow Articles by Tilvis, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sobel, E.
Right arrow Articles by Tilvis, R.

Neurology, Vol 45, Issue 5 903-907, Copyright © 1995 by American Academy of Neurology


ARTICLES

Lack of association of apolipoprotein E allele epsilon 4 with late- onset Alzheimer's disease among Finnish centenarians

E Sobel, J Louhija, R Sulkava, Z Davanipour, K Kontula, H Miettinen, M Tikkanen, K Kainulainen and R Tilvis
Department of Preventive Medicine, University of Southern California School of Medicine, Los Angeles 90033, USA.

No association between Alzheimer's disease (AD) and apolipoprotein E type epsilon 4 (ApoE epsilon 4) phenotype was found among centenarians in Finland (N = 179). The data are based on ascertainment of all centenarians in Finland in 1991. All examinations were conducted during 1991. The diagnoses of dementia and AD were based on clinical grounds, conforming to DSM-III-R and NINCDS-ADRDA criteria. The percentage of ApoE epsilon 4 alleles among the centenarians was 8.7% (31 of 358 alleles). This is significantly lower than percentages found in younger Finnish populations. Thirty (16.8%) of the 179 centenarians were epsilon 4 allele carriers. One hundred fifty-one (84.4%) of the centenarians were women. Twenty-eight (18.5%) of the women had at least one epsilon 4 allele, as did two (7.1%) of the men. The prevalence of clinically diagnosed AD was 26.8%; 44% of the subjects were cognitively normal, 23% had signs of cognitive decline or at most mild dementia (with no differential diagnosis), and 6% had a dementia clinically diagnosed as being due to some cause other than AD. For AD cases versus cognitively normal subjects, the odds ratio associated with being a carrier of the epsilon 4 allele was 1.34 (p = 0.64; 95% CI = [0.5, 3.3]). Among women, the odds ratio was 0.99 (p = 1.0; 95% CI = [0.4, 2.6]). There were fewer, but not significantly so, epsilon 4 carriers among subjects with cognitive decline or at most mild dementia (12.2%) than there were among the cognitively normal subjects (16.5%). The AD patients had no evidence of difficulty standing on a flat stationary surface unless the surface suddenly moved.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. F. Calvert Jr., J. Hollander-Rodriguez, J. Kaye, and M. Leahy
Dementia-free survival among centenarians: an evidence-based review.
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2006; 61(9): 951 - 956.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. M. Silverman, G. Ciresi, C. J. Smith, D. B. Marin, and M. Schnaider-Beeri
Variability of Familial Risk of Alzheimer Disease Across the Late Life Span
Arch Gen Psychiatry, May 1, 2005; 62(5): 565 - 573.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
C. M. Clark and J. H.T. Karlawish
Alzheimer Disease: Current Concepts and Emerging Diagnostic and Therapeutic Strategies
Ann Intern Med, March 4, 2003; 138(5): 400 - 410.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
J. M. Silverman, C. J. Smith, D. B. Marin, R. C. Mohs, and C. B. Propper
Familial Patterns of Risk in Very Late-Onset Alzheimer Disease
Arch Gen Psychiatry, February 1, 2003; 60(2): 190 - 197.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
T. Polvikoski, R. Sulkava, L. Myllykangas, I.-L. Notkola, L. Niinisto, A. Verkkoniemi, K. Kainulainen, K. Kontula, J. Perez-Tur, J. Hardy, et al.
Prevalence of Alzheimer's disease in very elderly people: A prospective neuropathological study
Neurology, June 26, 2001; 56(12): 1690 - 1696.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. B Psychol. Sci. Soc. Sci.Home page
K. Andersen-Ranberg, L. Vasegaard, and B. Jeune
Dementia Is Not Inevitable: A Population-Based Study of Danish Centenarians
J. Gerontol. B. Psychol. Sci. Soc. Sci., May 1, 2001; 56(3): P152 - P159.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
Z. Guo, L. Fratiglioni, M. Viitanen, L. Lannfelt, H. Basun, J. Fastbom, and B. Winblad
Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication?
Am. J. Epidemiol., February 1, 2001; 153(3): 225 - 231.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
G. W. Small, S. T. Chen, S. Komo, L. Ercoli, S. Bookheimer, K. Miller, H. Lavretsky, S. Saxena, A. Kaplan, D. Dorsey, et al.
Memory Self-Appraisal in Middle-Aged and Older Adults With the Apolipoprotein E-4 Allele
Am J Psychiatry, July 1, 1999; 156(7): 1035 - 1038.
[Abstract] [Full Text]


Home page
NeurologyHome page
Y. Itoh, M. Yamada, N. Sodeyama, N. Suematsu, M. Matsushita, E. Otomo, and H. Mizusawa
Atherosclerosis is not implicated in association of APOE {epsilon}4 with AD
Neurology, July 1, 1999; 53(1): 236 - 236.
[Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G. B Frisoni, M. Manfredi, C. Geroldi, G. Binetti, O. Zanetti, A. Bianchetti, and M. Trabucchi
The prevalence of apoE-epsilon 4 in Alzheimer's disease is age dependent
J. Neurol. Neurosurg. Psychiatry, July 1, 1998; 65(1): 103 - 106.
[Abstract] [Full Text]


Home page
Arch NeurolHome page
L. Berg, D. W. McKeel Jr, J. P. Miller, M. Storandt, E. H. Rubin, J. C. Morris, J. Baty, M. Coats, J. Norton, A. M. Goate, et al.
Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer Disease: Relation of Histologic Markers to Dementia Severity, Age, Sex, and Apolipoprotein E Genotype
Arch Neurol, March 1, 1998; 55(3): 326 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
I. Skoog, C. Hesse, O. Aevarsson, S. Landahl, J. Wahlström, P. Fredman, and K. Blennow
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality
J. Neurol. Neurosurg. Psychiatry, January 1, 1998; 64(1): 37 - 43.
[Abstract] [Full Text]


Home page
StrokeHome page
L. Ferrucci, J. M. Guralnik, M. Pahor, T. Harris, M.-C. Corti, M.-C. MHS, B. T. Hyman, R. B. Wallace, and R. J. Havlik
Apolipoprotein E {epsilon}2 Allele and Risk of Stroke in the Older Population
Stroke, December 1, 1997; 28(12): 2410 - 2416.
[Abstract] [Full Text]


Home page
ScienceHome page
C. E. Finch and R. E. Tanzi
Genetics of Aging
Science, October 17, 1997; 278(5337): 407 - 411.
[Abstract] [Full Text]


Home page
StrokeHome page
Y. Itoh, M. Yamada, N. Suematsu, M. Matsushita, and E. Otomo
Influence of Apolipoprotein E Genotype on Cerebral Amyloid Angiopathy in the Elderly
Stroke, February 1, 1996; 27(2): 216 - 218.
[Abstract] [Full Text]


Home page
NEJMHome page
T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinisto, P. Halonen, and K. Kontula
Apolipoprotein E, Dementia, and Cortical Deposition of {beta}-Amyloid Protein
N. Engl. J. Med., November 9, 1995; 333(19): 1242 - 1248.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.